510(k) K895995
K895995 is an FDA 510(k) premarket notification submitted by Lipogen, Inc. for the device "RHEUMELISA ASSAY FOR SS-B/LA AUTOANTIBODIES". The FDA issued a decision of Substantially Equivalent on Oct 27, 1989. The device falls under product code LJM (Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls), a Class II device regulated under 21 CFR 866.5100. Lipogen, Inc. has 14 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Oct 27, 1989
- Date Received
- Oct 13, 1989
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Antinuclear Antibody (Enzyme-Labeled), Antigen, Controls
- Device Class
- Class II
- Regulation Number
- 866.5100
- Review Panel
- IM
- Submission Type
- 510(k)
Need the full FDA record for Lipogen, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.